Washington, D.C. – Advocates and volunteers from the Patient Quality of Life Coalition (PQLC) will be on Capitol Hill today to share their stories with lawmakers as part of the coalition’s sixth annual lobby day.
Today the U.S. House is poised to pass an FY 2020 spending bill that includes a $2 billion funding increase for the National Institutes of Health (NIH) including a $300 million funding boost for the National Cancer Institute (NCI).
WASHINGTON, D.C. – On May 15, U.S. District Judge Paul W.
Washington, D.C. – The American Cancer Society Cancer Action Network (ACS CAN) is launching a new initiative this week that will promote the experiences of cancer survivors in cancer-related policymaking.
Washington, D.C– June 11, 2019 – The U.S. Department of Veterans Affairs (DVA) announced yesterday that it will adopt a smoke-free policy for patients, visitors, contractors, volunteers and other vendors at all DVA health care facilities.
Washington, D.C. – Today Senate Majority Leader Mitch McConnell (R-Ky.) and Sen. Tim Kaine (D-Va.) introduced legislation that would raise the federal age of sale for tobacco products from 18 to 21.
Today the U.S. House of Representatives is expected to vote on a legislative package aimed at protecting and improving access to affordable health care and prescription drugs, including for those with serious pre-existing conditions like cancer.
WASHINGTON, D.C. – In a major victory for America’s kids and public health, a federal judge ruled Wednesday that, in August 2017, the U.S.
Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ‘six protected classes’ of cancer, epilepsy, HIV/AIDS, mental illness and organ transplants.
The American Cancer Society Cancer Action Network (ACS CAN) launched an ad campaign this week highlighting deep concerns from cancer patients and survivors over the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on their access to critical drug therapies.